INS and metabolic dysfunction-associated steatohepatitis: Moreover, in a recent study, high-dose oral vitamin D3 supplementation (25,000 IU/week) over 24 weeks had no impact on liver histology, liver biochemistry, insulin resistance or adipocytokine profile in 12 non-diabetic patients with biopsy-proven NASH [29].